These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15747585)

  • 21. Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008).
    Tomic V; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2014 Nov; 13():52. PubMed ID: 25376749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Morphological changes in penicillin-resistant Streptococcus pneumoniae and beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae after exposure to oral antibacterial agents].
    Chiba N; Morozumi M; Ubukata K
    Jpn J Antibiot; 2012 Oct; 65(5):323-34. PubMed ID: 23383434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.
    Thornsberry C; Ogilvie PT; Holley HP; Sahm DF
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2612-23. PubMed ID: 10543737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics].
    Takenaka M; Morikawa Y; Nakagawa T; Takashima T; Haruta T; Tsuji T
    Jpn J Antibiot; 1999 Feb; 52(2):162-71. PubMed ID: 10221181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM; Suter M; Borsos S
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial activity of oral Cephems against various clinically isolated strains].
    Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
    Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan.
    Lau YJ; Hsueh PR; Liu YC; Shyr JM; Huang WK; Teng LJ; Liu CY; Luh KT
    Microb Drug Resist; 2006; 12(2):130-5. PubMed ID: 16922631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005.
    Sener B; Tunçkanat F; Ulusoy S; Tünger A; Söyletir G; Mülazimoğlu L; Gürler N; Oksüz L; Köksal I; Aydin K; Yalçin AN; Oğünç D; Acar A; Sievers J
    J Antimicrob Chemother; 2007 Sep; 60(3):587-93. PubMed ID: 17597058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000.
    Critchley IA; Blosser-Middleton R; Jones ME; Yamakita J; Aswapokee N; Chayakul P; Tharavichitukul P; Vibhagool A; Thornsberry C; Karlowsky JA; Sahm DF
    J Chemother; 2002 Apr; 14(2):147-54. PubMed ID: 12017369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey.
    Gonullu N; Catal F; Kucukbasmaci O; Ozdemir S; Torun MM; Berkiten R
    Chemotherapy; 2009; 55(3):161-7. PubMed ID: 19390189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004).
    Inoue M; Farrell DJ; Kaneko K; Akizawa K; Fujita S; Kaku M; Igari J; Yamaguchi K; Yamanaka K; Murase M; Asari S; Hirakata Y; Baba H; Itaha H
    Microb Drug Resist; 2008 Jun; 14(2):109-17. PubMed ID: 18500920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
    Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN;
    Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
    Sahm DF; Brown NP; Thornsberry C; Jones ME
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial.
    Darabi A; Hocquet D; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2010 May; 67(1):78-86. PubMed ID: 20385351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan.
    Inoue M; Kohno S; Kaku M; Yamaguchi K; Igari J; Yamanaka K
    Int J Infect Dis; 2005 Jan; 9(1):27-36. PubMed ID: 15603993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
    Fuchs PC; Barry AL; Brown SD
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):265-9. PubMed ID: 10974578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.